Media stories about The Ensign Group (NASDAQ:ENSG) have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. The Ensign Group earned a daily sentiment score of 0.12 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.1317348931418 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

These are some of the headlines that may have impacted Accern Sentiment’s scoring:

Shares of The Ensign Group (NASDAQ:ENSG) traded up 0.09% during trading on Thursday, hitting $23.04. The stock had a trading volume of 79,952 shares. The firm’s 50 day moving average is $20.81 and its 200 day moving average is $20.16. The Ensign Group has a 1-year low of $16.51 and a 1-year high of $23.69. The company has a market cap of $1.17 billion, a PE ratio of 26.82 and a beta of 0.87.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Saturday, September 30th will be issued a $0.043 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.17 annualized dividend and a dividend yield of 0.75%. The Ensign Group’s payout ratio is currently 20.24%.

Several equities analysts have recently issued reports on the company. Zacks Investment Research lowered The Ensign Group from a “hold” rating to a “sell” rating in a research note on Tuesday, August 8th. TheStreet upgraded The Ensign Group from a “c+” rating to a “b” rating in a research note on Monday, August 7th. Finally, BidaskClub lowered The Ensign Group from a “buy” rating to a “hold” rating in a research note on Sunday, August 6th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $22.00.

TRADEMARK VIOLATION NOTICE: This piece was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at

In related news, VP Barry Port sold 10,000 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $23.00, for a total value of $230,000.00. Following the transaction, the vice president now owns 135,642 shares of the company’s stock, valued at $3,119,766. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Antoinette T. Hubenette sold 2,500 shares of the stock in a transaction on Tuesday, September 12th. The shares were sold at an average price of $20.95, for a total value of $52,375.00. Following the completion of the transaction, the director now directly owns 24,626 shares in the company, valued at approximately $515,914.70. The disclosure for this sale can be found here. In the last three months, insiders sold 14,576 shares of company stock worth $327,373. 6.20% of the stock is owned by insiders.

About The Ensign Group

The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.

Insider Buying and Selling by Quarter for The Ensign Group (NASDAQ:ENSG)

Receive News & Stock Ratings for The Ensign Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group Inc. and related stocks with our FREE daily email newsletter.